Hepatitis B Virus Core Antigen (HBcAg) (AA 135-140) anticorps

N° du produit ABIN111728

L’anticorps anti-Hepatitis B Virus Core Antigen Monoclonal Souris est utilisé pour la détection de Hepatitis B Virus Core Antigen dans des échantillons de Hepatitis B Virus (HBV). Il a été validé pour WB, IF, EIA et IP.

Aperçu rapide pour Hepatitis B Virus Core Antigen (HBcAg) (AA 135-140) anticorps (ABIN111728)

Antigène: Hepatitis B Virus Core Antigen (HBcAg)

Reactivité: Hepatitis B Virus (HBV)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA), Immunoprecipitation (IP)

Clone: 13A9

Détail du produit

Épitope: AA 135-140

Purification: Protein A chromatography.

Immunogène: Recombinant HBcAg core antigen (ayw)

Isotype: IgG2b

Information d'application

Indications d'application: Immunofluorescence, ELISA, Western blot, Immunoprecipitation of in vitro-translated coreand pre-core proteins.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS, pH 7.4 without preservatives.

Agent conservateur: Without preservative

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détail du antigène

Antigène: Hepatitis B Virus Core Antigen (HBcAg)

Autre désignation: Hepatitis B Core Antigen / HBcAg

Classe de substances: Viral Protein

Sujet: Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner "core particle" enclosing the viral genome. The icosahedral core particle contains 180 or 240 copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection. The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection.Synonyms: HBV Capsid protein, HBV Core protein, p21.5